Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spinal Aspergillosis: Case Report.

International journal of spine surgery·2026

Same author

Sex-Related Differences in Outcomes and Thresholds for Intervention in Primary Mitral Regurgitation: A Systematic Review and Meta-Analysis.

JACC. Cardiovascular imaging·2026

Same author

Aortic arch replacement with descending thoracic aorta stenting for chronic dissection: early outcomes.

Journal of cardiothoracic surgery·2026

Same author

Evolving Perspectives in Surgery for Mitral Regurgitation: Why Sex Matters.

Journal of the American Heart Association·2025

Same author

Investigating the epigenetic basis for aortic aneurysm risk in patients with bicuspid aortic valve disease.

Perfusion·2025

Same author

Society of cardiothoracic surgery in great Britain and Ireland guidance for adult mitral valve disease and interventions.

BMJ surgery, interventions, & health technologies·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Prolonged survival with left atrial spindle cell sarcoma.

Amit Modi¹, Arturas Lipnevicius, Narain Moorjani

¹Wessex Cardiothoracic Centre, Southampton University Hospitals NHS Trust, Southampton, UK.

Interactive Cardiovascular and Thoracic Surgery

|March 24, 2009

Summary

Primary spindle cell sarcoma of the left atrium is rare. Complete surgical resection offers the best chance for survival, despite challenges and poor prognosis with other treatments.

More Related Videos

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Related Experiment Videos

Last Updated: Jun 24, 2026

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Area of Science:

Cardiovascular Surgery
Surgical Oncology
Cardiac Tumors

Background:

Primary spindle cell sarcoma of the left atrium is an exceptionally rare and aggressive malignancy.
Surgical resection is the primary treatment modality, yet poses significant challenges due to tumor location and vital structure infiltration.

Observation:

A case report details the surgical management of a 48-year-old male with primary spindle cell sarcoma of the left atrium.
The patient underwent multiple surgical procedures to achieve complete tumor clearance.

Findings:

Complete surgical clearance, despite anatomical challenges, is crucial for managing primary spindle cell sarcoma of the left atrium.
The patient achieved an 11-year survival following extensive surgical intervention.

Implications:

This case highlights the importance of aggressive surgical strategies in rare cardiac sarcomas.
Further research into multimodality treatments may improve outcomes for patients with primary cardiac sarcoma, given their resistance to chemotherapy and radiotherapy.